“ “Screening with Qvintip is cost-effective for population-based cervical cancer prevention with the potential to improve health benefits to a lower cost than HPV reflex, conventional cytologi and repeat Pap smear.” ”
Qvintip® Self-sampling for HPV analysis
Qvintip® has been designed and developed for self-sampling and has initially been evaluated in collaboration with the Cytological Laboratory, Uppsala University Hospital, Sweden.
Studies show that Qvintip® can:
Increase participation in screening programs
(Sanner et al, British Journal of Cancer 2009:101:871-874, Stenval et al, Actaderm Venereol 2007:87:243-245)
Increase specificity of screening women 30-64 years old (Gyllensten et al, British Journal of Cancer 2011:105(5):694-7)
Improve detection of CIN2-3 lesions compared to cytology
(Wikström et al, British Journal of Cancer 2011:105(3):337-9)
